JP2013508391A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013508391A5 JP2013508391A5 JP2012535346A JP2012535346A JP2013508391A5 JP 2013508391 A5 JP2013508391 A5 JP 2013508391A5 JP 2012535346 A JP2012535346 A JP 2012535346A JP 2012535346 A JP2012535346 A JP 2012535346A JP 2013508391 A5 JP2013508391 A5 JP 2013508391A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- antibody
- antigen
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25347409P | 2009-10-20 | 2009-10-20 | |
| US61/253,474 | 2009-10-20 | ||
| PCT/US2010/053433 WO2011050104A2 (en) | 2009-10-20 | 2010-10-20 | Methods of using anti-cd3 antibodies to prevent weight gain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013508391A JP2013508391A (ja) | 2013-03-07 |
| JP2013508391A5 true JP2013508391A5 (enExample) | 2013-12-05 |
Family
ID=43900946
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012535346A Pending JP2013508391A (ja) | 2009-10-20 | 2010-10-20 | 体重増加を予防するために抗ｃｄ３抗体を使用する方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20130171142A1 (enExample) |
| EP (1) | EP2490719A4 (enExample) |
| JP (1) | JP2013508391A (enExample) |
| CA (1) | CA2778331A1 (enExample) |
| WO (1) | WO2011050104A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL264502B2 (en) * | 2016-08-29 | 2023-09-01 | Tiziana Life Sciences Plc | Anti-cd3 antibody formulations |
| BR112021022682A2 (pt) | 2019-05-14 | 2022-02-22 | Provention Bio Inc | Métodos e composições para prevenir diabetes do tipo 1 |
| US12006366B2 (en) | 2020-06-11 | 2024-06-11 | Provention Bio, Inc. | Methods and compositions for preventing type 1 diabetes |
| WO2022251253A1 (en) | 2021-05-24 | 2022-12-01 | Provention Bio, Inc. | Methods for treating type 1 diabetes |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8064994B2 (en) * | 2003-01-14 | 2011-11-22 | The United States Of America As Represented By The Department Of Veterans Affairs | Cervical vagal stimulation induced weight loss |
| EP1858545A2 (en) * | 2005-03-04 | 2007-11-28 | Curedm Inc. | Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions |
| US20090258001A1 (en) * | 2006-06-06 | 2009-10-15 | Paul Ponath | Administration of anti-CD3 antibodies in the treatment of autoimmune diseases |
-
2010
- 2010-10-20 JP JP2012535346A patent/JP2013508391A/ja active Pending
- 2010-10-20 US US13/502,625 patent/US20130171142A1/en not_active Abandoned
- 2010-10-20 CA CA2778331A patent/CA2778331A1/en not_active Abandoned
- 2010-10-20 EP EP10825627.2A patent/EP2490719A4/en not_active Withdrawn
- 2010-10-20 WO PCT/US2010/053433 patent/WO2011050104A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010229134A5 (enExample) | ||
| JP2011509245A5 (enExample) | ||
| AU2013206788B2 (en) | Method of providing monoclonal auto-antibodies with desired specificity | |
| HRP20170815T1 (hr) | Agonisti receptora 1 fibroblastnog čimbenika rasta i postupci uporabe | |
| JP2012501670A5 (enExample) | ||
| JP2020500542A5 (enExample) | ||
| JP2020023523A5 (enExample) | ||
| JP2011520898A5 (enExample) | ||
| JP2009502171A5 (enExample) | ||
| JP2021515566A5 (enExample) | ||
| JP2005526501A5 (enExample) | ||
| US10875916B2 (en) | Nucleic acid molecules encoding monoclonal antibodies specific for IL-17F | |
| JP2010500005A5 (enExample) | ||
| JP2019512464A5 (enExample) | ||
| JP2010526028A5 (enExample) | ||
| JP2012139223A5 (enExample) | ||
| WO2007033230A2 (en) | Anti-cd3 antibody formulations | |
| JP2018500014A5 (enExample) | ||
| CN108367075A (zh) | 4-1bb结合蛋白及其用途 | |
| JP2014039548A5 (enExample) | ||
| JP2020002172A5 (enExample) | ||
| JP2009225799A5 (enExample) | ||
| JP2017505121A5 (enExample) | ||
| JP2011526785A5 (enExample) | ||
| JP2012531922A5 (ja) | Ｔｏｌｌ様受容体２へのヒト化抗体またはその抗原結合部位 |